PCVAX | VSIAX | PCVAX / VSIAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 28 years | 13 years | - |
Gain YTD | 10.886 | 15.498 | 70% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 320M | 57.6B | 1% |
Annual Yield % from dividends | 2.15 | 2.01 | 107% |
Returns for 1 year | 15.92 | 28.76 | 55% |
Returns for 3 years | -18.84 | 13.29 | -142% |
Returns for 5 years | -9.04 | 57.44 | -16% |
Returns for 10 years | -57.71 | 108.79 | -53% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DLDRX | 49.62 | -0.11 | -0.22% |
BNY Mellon Natural Resources I | |||
TRGVX | 18.16 | -0.09 | -0.49% |
T. Rowe Price Glbl Val Eq | |||
VBCVX | 15.64 | -0.11 | -0.70% |
VALIC Company I Systematic Value | |||
UUPIX | 49.34 | -0.40 | -0.80% |
ProFunds UltraEmerging Markets Inv | |||
JHIGX | 26.80 | -0.22 | -0.81% |
JHancock International Growth R2 |